Your browser doesn't support javascript.
loading
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.
van Houdt, Winan J; Fiore, Marco; Barretta, Francesco; Rutkowski, Piotr; Blay, Jean-Yves; Lahat, Guy; Strauss, Dirk; Gonzalez, Ricardo J; Ahuja, Nita; Grignani, Giovanni; Quagliuolo, Vittorio; Stoeckle, Eberhard; De Paoli, Antonino; Schrage, Yvonne; Cardona, Kenneth; Pennacchioli, Elisabetta; Pillarisetty, Venu G; Nessim, Carolyn; Swallow, Carol J; Bagaria, Sanjay P; Canter, Robert; Mullen, John T; Callegaro, Dario; Fairweather, Mark; Miceli, Rosalba; Raut, Chandrajit P; Gronchi, Alessandro; Gladdy, Rebecca A.
Affiliation
  • van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Fiore M; Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Barretta F; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland.
  • Blay JY; Department of Medical Oncology, Leon Berard Center, Claude Bernard Lyon 1 University, Lyon, France.
  • Lahat G; Department of General Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Strauss D; Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, London, United Kingdom.
  • Gonzalez RJ; Sarcoma Department, Moffitt Cancer Center, Tampa, Florida.
  • Ahuja N; Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
  • Grignani G; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Quagliuolo V; Surgical Oncology Unit, Humanitas Clinical Institute IRCCS, Milan, Italy.
  • Stoeckle E; Department of Surgery, Bergonie Institute, Regional Cancer Centre, Bordeaux Cedex, France.
  • De Paoli A; Department of Radiation Oncology, Oncology Reference Center (CRO), CRO-IRCCS, Aviano, Italy.
  • Schrage Y; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Cardona K; Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Pennacchioli E; Division of Melanoma and Sarcoma, European Institute of Oncology IRCCS, Milan, Italy.
  • Pillarisetty VG; Department of Surgery, Seattle Cancer Care Alliance, University of Washington School of Medicine, Seattle, Washington.
  • Nessim C; Department of Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Swallow CJ; Division of General Surgery, Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Bagaria SP; Section of Surgical Oncology, Department of Surgery, Mayo Clinic Jacksonville, Jacksonville, Florida.
  • Canter R; Department of Surgery, University of California at Davis School of Medicine, Davis, California.
  • Mullen JT; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Callegaro D; Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Fairweather M; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Miceli R; Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Raut CP; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Gronchi A; Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gladdy RA; Division of General Surgery, Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Cancer ; 126(22): 4917-4925, 2020 11 15.
Article in En | MEDLINE | ID: mdl-32797703
ABSTRACT

BACKGROUND:

In this series from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), the authors examined longitudinal outcomes of patients with a second recurrence of retroperitoneal sarcoma (RPS) after complete resection of a first local recurrence (LR).

METHODS:

Data from patients undergoing resection of a first LR from January 2002 to December 2011were collected from 22 sarcoma centers. The primary outcome was overall survival (OS) after second recurrence.

RESULTS:

Second recurrences occurred in 400 of 567 patients (70.5%) after an R0/R1 resection of a first locally recurrent RPS. Patterns of disease recurrence were LR in 323 patients (80.75%), distant metastases (DM) in 55 patients (13.75%), and both LR and DM in 22 patients (5.5%). The main subtype among the LR group was liposarcoma (77%), whereas DM mainly were leiomyosarcomas (43.6%). In patients with a second LR only, a total of 200 patients underwent re-resection (61.9%). The 5-year OS rate varied significantly based on the pattern of failure (P < .001) 45.6% for the LR group, 25.5% for the DM group, and 0% for the group with LR and DM. The only factors found to be associated with improved OS on multivariable analysis were both time between second surgery and the development of the second recurrence (32 months vs 8 months hazard ratio, 0.44 [P < .001]) and surgery for second recurrence (yes vs no hazard ratio, 3.25 [P < .001]). The 5-year OS rate for patients undergoing surgery for a second LR was 59% versus 18% in the patients not deemed suitable for surgical resection.

CONCLUSIONS:

Survival rates after second recurrence of RPS varied based on patterns of disease recurrence and treatment. Durable disease-free survivors were identified after surgery for second LR in patients selected for this intervention.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Sarcoma Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2020 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Sarcoma Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2020 Type: Article Affiliation country: Netherlands